Trials / Completed
CompletedNCT03240939
Pharmacokinetics and Safety/Tolerability of YY-201 in Comparison to Dutasteride and Tadalafil
A Randomized, Open Label, Single Dose, Two-way Crossover Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of YY-201 in Comparison to Dutasteride and Tadalafil Administered in Healthy Male Volunteer
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Yuyu Pharma, Inc. · Industry
- Sex
- Male
- Age
- 19 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
A randomized, open label, single dose, two-way crossover clinical trial to investigate the pharmacokinetics and safety/tolerability of YY-201 in comparison to Dutasteride and Tadalafil administered in healthy male volunteers
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dutasteride 0.5 mg | single dose |
| DRUG | Tadalafil 5 mg | single dose |
| DRUG | YY-201 | single dose |
Timeline
- Start date
- 2017-03-27
- Primary completion
- 2017-07-07
- Completion
- 2017-10-10
- First posted
- 2017-08-07
- Last updated
- 2017-11-24
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03240939. Inclusion in this directory is not an endorsement.